177 related articles for article (PubMed ID: 27563925)
1. Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90.
Henke A; Franco OE; Stewart GD; Riddick AC; Katz E; Hayward SW; Thomson AA
Cancers (Basel); 2016 Aug; 8(9):. PubMed ID: 27563925
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
Tomcik M; Zerr P; Pitkowski J; Palumbo-Zerr K; Avouac J; Distler O; Becvar R; Senolt L; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1215-22. PubMed ID: 23661493
[TBL] [Abstract][Full Text] [Related]
5. Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo.
Moser C; Lang SA; Kainz S; Gaumann A; Fichtner-Feigl S; Koehl GE; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Ther; 2007 Nov; 6(11):2868-78. PubMed ID: 18025273
[TBL] [Abstract][Full Text] [Related]
6. Reduction of pro-tumorigenic activity of human prostate cancer-associated fibroblasts using Dlk1 or SCUBE1.
Orr B; Grace OC; Brown P; Riddick AC; Stewart GD; Franco OE; Hayward SW; Thomson AA
Dis Model Mech; 2013 Mar; 6(2):530-6. PubMed ID: 23136397
[TBL] [Abstract][Full Text] [Related]
7. 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.
Karkoulis PK; Stravopodis DJ; Voutsinas GE
Tumour Biol; 2016 May; 37(5):6861-73. PubMed ID: 26662567
[TBL] [Abstract][Full Text] [Related]
8. In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines.
Ghadban T; Jessen A; Reeh M; Dibbern JL; Mahner S; Mueller V; Wellner UF; Güngör C; Izbicki JR; Vashist YK
Int J Mol Med; 2016 Oct; 38(4):1296-302. PubMed ID: 27498942
[TBL] [Abstract][Full Text] [Related]
9. Amplified canonical transforming growth factor-β signalling
Sibinska Z; Tian X; Korfei M; Kojonazarov B; Kolb JS; Klepetko W; Kosanovic D; Wygrecka M; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Guenther A; Schermuly RT
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28182573
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma.
Dourado MR; Korvala J; Åström P; De Oliveira CE; Cervigne NK; Mofatto LS; Campanella Bastos D; Pereira Messetti AC; Graner E; Paes Leme AF; Coletta RD; Salo T
J Extracell Vesicles; 2019; 8(1):1578525. PubMed ID: 30788085
[TBL] [Abstract][Full Text] [Related]
11. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
12. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
[TBL] [Abstract][Full Text] [Related]
13. Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth.
Lang SA; Moser C; Gaumann A; Klein D; Glockzin G; Popp FC; Dahlke MH; Piso P; Schlitt HJ; Geissler EK; Stoeltzing O
Clin Cancer Res; 2007 Nov; 13(21):6459-68. PubMed ID: 17975158
[TBL] [Abstract][Full Text] [Related]
14. 17-DMAG-loaded nanofibrous scaffold for effective growth inhibition of lung cancer cells through targeting HSP90 gene expression.
Mellatyar H; Talaei S; Pilehvar-Soltanahmadi Y; Dadashpour M; Barzegar A; Akbarzadeh A; Zarghami N
Biomed Pharmacother; 2018 Sep; 105():1026-1032. PubMed ID: 30021337
[TBL] [Abstract][Full Text] [Related]
15. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment.
Yeh CR; Slavin S; Da J; Hsu I; Luo J; Xiao GQ; Ding J; Chou FJ; Yeh S
Mol Cancer; 2016 Jan; 15():7. PubMed ID: 26790618
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of [
Vermeulen K; Naus E; Ahamed M; Attili B; Siemons M; Luyten K; Celen S; Schymkowitz J; Rousseau F; Bormans G
Theranostics; 2019; 9(2):554-572. PubMed ID: 30809293
[TBL] [Abstract][Full Text] [Related]
19. Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition.
Kim DJ; Dunleavey JM; Xiao L; Ollila DW; Troester MA; Otey CA; Li W; Barker TH; Dudley AC
Br J Cancer; 2018 May; 118(10):1359-1368. PubMed ID: 29695769
[TBL] [Abstract][Full Text] [Related]
20. An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors.
Dakappagari N; Neely L; Tangri S; Lundgren K; Hipolito L; Estrellado A; Burrows F; Zhang H
Biomarkers; 2010 Feb; 15(1):31-8. PubMed ID: 19747088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
